Pleural atypical mesothelial hyperplasia: An early stage of pleural malignant mesothelioma?

T. Vandemoortele, S. Laroumagne, O. Bylicki, S. Giusiano, H. Dutau, P. Astoul (Marseille, France)

Source: Annual Congress 2012 - Clinical issues in malignant pleural effusions
Session: Clinical issues in malignant pleural effusions
Session type: Thematic Poster Session
Number: 1257
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Vandemoortele, S. Laroumagne, O. Bylicki, S. Giusiano, H. Dutau, P. Astoul (Marseille, France). Pleural atypical mesothelial hyperplasia: An early stage of pleural malignant mesothelioma?. Eur Respir J 2012; 40: Suppl. 56, 1257

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Management of malignant pleural mesothelioma
Source: ERS Skills Course 2015
Year: 2015

Management of malignant pleural mesothelioma
Source: School Course 2014 - Medical Thoracoscopy
Year: 2014

Management of malignant pleural mesothelioma
Source: Hands-on Course 2013 - Medical Thoracoscopy
Year: 2013

Management of malignant pleural mesothelioma
Source: ERS Course 2016 - Skills course on medical thoracoscopy
Year: 2016

Management of malignant pleural mesothelioma
Source: Hands-on Course 2012 - Medical Thoracoscopy
Year: 2012

Pathological diagnosis of malignant pleural mesothelioma
Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases
Year: 2020

Diagnosis of malignant pleural mesothelioma
Source: Eur Respir J 2004; 24: Suppl. 48, 527s
Year: 2004

Bevacizumab-targeted therapy for malignant pleural mesothelioma
Source: International Congress 2017 – Malignant pleural effusion management in 2017: a review of recent RCTs
Year: 2017


Non-malignant pleural disease from asbestos and malignant pleural mesothelioma
Source: Eur Respir Monogr 2020; 89: 141-149
Year: 2020


The radiologic evidance in distinguishing the pleural mesothelioma from the pleural metastatic adenocarcinoma
Source: Eur Respir J 2006; 28: Suppl. 50, 93s
Year: 2006

Thoracoscopy and malignant pleural mesothelioma
Source: ERS Course 2015
Year: 2015

Mesothelioma in situ with regressive malignant pleural effusion. A year latter
Source: Virtual Congress 2021 – CCC Thoracic oncology
Year: 2021


A rare case of malignant pleural mesothelioma presenting with multiple metastatic pulmonary nodules
Source: Annual Congress 2011 - Pleural and mediastinal malignancies: management and rare clinical cases
Year: 2011

Treatment of malignant pleural mesothelioma: dilemmas
Source: Eur Respir J 2005; 26: Suppl. 49, 73s
Year: 2005

Cytology of pleural fluid versus histopathology of the pleura in the diagnosis of malignant pleural effusions
Source: Eur Respir J 2006; 28: Suppl. 50, 775s
Year: 2006

A case report: surprising diagnosis of malignant mesothelioma in a patient with malignant pleural effusion, mediastinal lymphoma and intestinal carcinoma in situ
Source: Eur Respir J 2004; 24: Suppl. 48, 527s
Year: 2004

An update on treatment of malignant pleural effusion with or without known primary bronchial adenocarcinoma
Source: Annual Congress 2006 - Medical and surgical management of malignant pleuritis
Year: 2006


Dealing with diagnosis of benign and malignant pleural effusions
Source: Annual Congress 2010 - PG5 Postgraduate Course: Interventional thoracoscopy
Year: 2010